Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-specific protein Y-linked 2 (TSPY2) is a member of the TSPY (testis-specific protein, Y-encoded) gene family, located on the Y chromosome and expressed predominantly in male germ cells. TSPY2 is an ampliconic, multi-copy gene showing considerable copy number variation among individuals and species. Its expression is largely limited to embryonic and adult testis, particularly in germ cells during embryogenesis and spermatogenesis. Functionally, TSPY2 is involved in promoting proliferation and differentiation of male germ cells and is necessary for male embryo development, as knockdown results in developmental arrest at early embryonic stages. TSPY2 interacts with cell cycle regulators and may repress androgen receptor signaling, suppressing androgen-induced cell proliferation in testicular germ-cell tumors. High TSPY2 copy number and expression have been linked to infertility and testicular as well as prostate cancer. While TSPY2 may serve as a biomarker for certain male-specific cancers, it is not considered a classic therapeutic target (such as a receptor, enzyme, or transporter)[1][3][5]. Key notes: - TSPY2 is validated at the RNA/protein level in the testis and implicated in male development and fertility[5][3]. - It may act as a biomarker for testicular malignancy; knockdown studies show its essentiality in early male embryogenesis[3]. - It is not a classical “therapeutic target” since no known approved or investigational drugs act on TSPY2, nor is it categorized as a receptor or enzyme[1][3][5]. - Some sources (notably [4] and [6]) discuss related proteins (such as TSPYL2, a different gene on the X chromosome); this should not be confused with TSPY2, which is Y-linked[5]. - TSPYQ1 is functionally synonymous with TSPY2 in some annotations[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-specific protein Y-linked 2 (TSPY2).